Metagenomics Market

Increase in Diabetic Patients to Surge the Demand for Metagenomics: FMI Analyzes data from 30+ Countries

Metagenomics Market by Product Type, Application, End User & Region | Forecast 2023 to 2033

Metagenomics Market Snapshot (2023 to 2033)

As per the recent market research conducted by FMI, the global metagenomics market is expected to advance at a CAGR of 6.9% during the forecast period. The valuation in 2023 is expected to be US$ 202.9 million. By 2033, the market value is expected to be US$ 394.2 million.

Key factors that may propel the market growth are:

The rising use of metagenomics techniques across varied areas increased government and private sector investment in large-scale sequencing projects.
An increase in chronic illness cases, and breakthroughs in sequencing technology.
Rapid advances in sequencing methods have enabled humans to get a better grasp of previously undiscovered molecular genetics.
Metagenomics is gaining popularity for large-scale genomics applications aimed at determining the taxonomic and functional makeup of microbial communities.
The growing use of metagenomics in clinical diagnostics is propelling the metagenomics industry forward.

The COVID-19 pandemic is likely to redirect attention to the growing metagenomics business.

As per an article in Future Science, 2021, pandemic risk calculations use metagenomics to trace the molecular changes in pathogens during their emergence. This could aid in the prediction of hotspots of emergence, populations at risk, and pathogens undergoing genetic evolution. Given the foregoing, the COVID-19 pandemic is projected to have a substantial influence on the metagenomics analysis.

Collaborations between government and business entities are also expected to generate sales opportunities for metagenomics throughout the projected period. For example, in October 2021, the USA Food and Drug Administration, the National Institute of Health, and 15 commercial groups entered a strategic partnership. The idea was to discover gene therapy for 30 million Americans who suffer from uncommon diseases.

Key developments in the market include the advancement of sequencing technologies from shotgun sequencing to high-throughput, next-generation sequencing, and third-generation sequencing. These developments would provide an impetus for favorable growth opportunities for market players in the coming years.

As per the regional analysis, North America is expected to be the dominant market. The market will be driven by increased demand for metagenomic sequencing due to the existence of biotechnological firms, and the rising incidence of chronic illnesses. An increase in the number of human genome research initiatives and the adoption of improved diagnostic procedures are also expected to drive market growth.

Attributes	Value
Metagenomics Market Value (2022)	US$ 189.2 million
Metagenomics Market Expected Value (2023)	US$ 202.9 million
Metagenomics Market Forecast Value (2033)	US$ 394.2 million
Metagenomics Market Expected CAGR (2023 to 2033)	6.9%

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

Historical CAGR (2017 to 2022) vs Anticipated CAGR Trend Analysis

Metagenomics has been in demand owing to its ability to study every type of microorganism, regardless of whether it can be cultured or not. The ability to study prokaryotes and viruses in the environment through the analysis of their DNA makes metagenomics a powerful method. The capability to identify crucial bioactive compounds, enzymes, and antibiotics make metagenomics a highly reliable method. Owing to its increased usage the anticipated CAGR is expected to be more than the historical CAGR. The historical CAGR for the market was 6.4% and the anticipated CAGR is 6.9%.

Short-term (2023 to 2026): Increasing the prevalence of various chronic and infectious diseases such as cancer might surge the adoption of metagenomics for the timely diagnosis of these diseases. The growing adoption of metagenomics in clinical diagnostics is providing an impetus for market growth. Metagenomics assists in disease detection in crops and livestock by exploring the interaction between plants and microbes, which might drive the growth in this niche.
Medium-term (2026 to 2029): Rising adoption of metagenomics across diverse fields, and increasing investments by government and private agencies for large-scale sequencing projects might happen during this period. Rapid advancements in sequencing tools have allowed for a greater understanding of molecular genetics which was previously unknown to humans. Metagenomics might also gain immense traction for large-scale genomics applications to study the taxonomic and functional composition of microbial communities.
Long-term (2029 to 2033): Growing demand for fuels and biofuels across the world is anticipated to further accelerate the market growth over the assessment period. Metagenomics might become one of the promising research tools for discovering novel enzymes to produce biofuel in an efficient way across industries.

How is Increasing Adoption of Metagenomics in Chronic Disease Diagnosis boosting Sales?

As the global burden of chronic diseases continues to rise, research is conducted to test the potentiality of metagenomics for timely diagnosis. This is anticipated to bolster the growth in the metagenomics market.

Metagenomic diagnostics help predict and manage the treatment of a plethora of diseases. It can be effectively used to discover hidden genetic features that could prove vital in various usages. Key applications are in novel enzymes, bioactive molecules, and genes with better or new biochemical functionalities.

In addition, the growing adoption of diagnostic tests based on metagenomics for the early diagnosis of genetic disorders will further expand the market.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Will Growing Efforts for controlling Environmental Toxicology influence Demand?

Metagenomics plays a crucial role in bioremediation, a process that uses naturally occurring or artificially introduced microorganisms to break down environmental pollutants.

Metagenomic approaches reveal useful information about the metagenome of microorganisms, which play a key role in the biogeochemical cycles. These are also used for the detoxification of environmental pollutants using culture-independent molecular techniques.

Targeted metagenomics is used to study the phylogenetic diversity and relative abundance of a particular gene in the environment. The increasing need for preventing and controlling environmental toxicity through bioremediation will therefore create growth opportunities for the market.

Comparative View for Metagenomics Market

Metagenomics Market:

Attributes	Metagenomics Market
Anticipated CAGR (2023 to 2033)	6.9%
Market Value (2023)	US$ 202.9 million
Growth Factor	The surge in chronic illness
Future Opportunities	Increased government and private sector investment
Market Trends	Advancements in sequencing tools

Health and Medical Microalgae Market:

Attributes	Health and Medical Microalgae Market
Anticipated CAGR (2023 to 2033)	6%
Market Value (2023)	US$ 725 million
Growth Factor	Surging demand for natural ingredients in healthcare
Future Opportunities	Increase in consumption of clean-label products
Market Trends	Manufacturers focus on consumers who suffer from lifestyle diseases

Algae Omega Market:

Attributes	Algae Omega Market
Anticipated CAGR (2023 to 2033)	4%
Market Value (2023)	US$ 1,063.4 million
Growth Factor	Massive demand for clinical nutrition
Future Opportunities	Burgeoning demand for animal feeds
Market Trends	Manufacturers lay special emphasis on millennials

Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Sign-Up

Country-wise Insights

Regions	North America
Countries	United States of America
CAGR (2023 to 2033)	8%
Regions	Europe
Countries	United Kingdom
CAGR (2023 to 2033)	5.8%
Regions	Asia Pacific
Countries	China, Japan, India
CAGR (2023 to 2033)	8.6%, 5.3%, 6.8%

Will the USA market continue witnessing high demand?

Rising prevalence of chronic diseases fueling the adoption of metagenomic sequencing

The USA is projected to dominate the North American market over the forecast period. Increasing demand for metagenomic sequencing due to the heavy presence of biotechnological companies and the rising prevalence of chronic diseases are expected to drive the market. A surge in the number of human genome research projects and the adoption of better diagnostic techniques might as well propel growth.

Attributes	Details
United States of America Market Expected Size (2033)	US$ 110.3 million
United States of America Market Absolute Dollar Growth	US$ 59.4 million
CAGR % 2017 to 2022	6.2%

The USA is home to some of the leading pharmaceutical and biotech companies in the world. These companies are constantly employing techniques such as metagenomic sequencing for studying the nature and pattern of diseases as well as for developing targeted medicines.

What is the United Kingdom market outlook?

The heavy presence of end-use industries generates demand for metagenomic approaches like shotgun sequencing in the United Kingdom

The United Kingdom market is slated to grow at a robust pace over the forecast period, owing to the presence of leading end-use industries, and the growing popularity of shotgun sequencing. The high prevalence of genetic disorders and the continuous rise in genetic research projects are also expected to surge the growth.

Attributes	Details
United Kingdom Market Expected Size (2033)	US$ 11.1 million
United Kingdom Market Absolute Dollar Growth	US$ 4.8 million
CAGR % 2017 to 2022	8.8%

Increasing efforts by the government and private organizations to make the United Kingdom an advanced genomic healthcare system market. The country is one of the leading players in genetics and genome sequencing and spends billions of dollars on developing new diagnostic tools and drugs for a wide range of diseases.

What is driving the China market?

Increasing investments in gene research triggering growth in China

As per FMI, China is anticipated to lead the metagenomics market across the Asia Pacific excluding the Japan region throughout the forecast period. Growth in the market is driven by increasing demand for genetic sequencing, the prevalence of infectious diseases, and increasing investments in gene research.

Attributes	Details
China Market Expected Size (2033)	US$ 40.2 million
China Market Absolute Dollar Growth	US$ 22.5 million
CAGR % 2017 to 2022	7.3%

Rising investments in the healthcare sector by the government and other organizations are expected to fuel the growth in the market. For instance, in 2017 China launched the world’s largest human genome research project of 100,000 people to document their genetic makeup.

The growing popularity of metagenomics-based advanced gene sequencing techniques across agricultural and pharmaceutical industries is positively impacting growth.

Japan market: Driven by wildlife conservation

The Japanese market is mainly driven by a number of endangered species, some of which are the Asian leopard cat, Blakiston’s fish-owl, brown spotted catshark, etc. The zoologists and wildlife veterinarians in Japan are laying a lot of emphasis on their protection.

Metagenomics plays a key role in their conservation. The DNA sequencing technology of metagenomics allows for the identification of microbiomes among and within the hosts. Incorporating the microbial host and biogeographic variation assists in the forest corridor assessments, which helps in gaining a proper understanding of microbial pathogens. Adoption of these methods would help in protecting endangered species.

Attributes	Details
Japan Market Expected Size (2033)	US$ 24.9 million
Japan Market Absolute Dollar Growth	US$ 10 million
CAGR % 2017 to 2022	5.8%

India: Massive number of diabetic patients to drive growth

India is home to numerous diabetic patients in the world. Based on a survey conducted in December 2022, there are more than 74 million adults who suffer from diabetes. This is to say that 1 in 6 adults suffer from diabetes.

Attributes	Details
India Market Expected Size (2033)	US$ 20.9 million
India Market Absolute Dollar Growth	US$ 10.1 million
CAGR % 2017 to 2022	7.4%

The metagenomic shotgun sequencing and metabolomic profiling identify specific human gut microbiota associated with diabetic retinopathy in type 2 diabetes. Healthcare has recently suggested a functional model for the development of autoimmunity for type 1 diabetes. These developments are expected to surge the demand for metagenomics in India.

Segmentation Insights

Segment	Product Type
Attributes	Library Preparation Kits
CAGR % 2017 to 2022	6.3%
CAGR % 2023 to 2033	7.2%
Segment	Application
Attributes	Clinical Diagnostics
CAGR % 2017 to 2022	6.8%
CAGR % 2023 to 2033	8.3%

Why is the demand for library preparation kits rising?

Sales of library preparation kits to rise at robust pa ace as gene sequencing gains centerstage

As per FMI, sales in the library preparation kits segment accounted for a share of 42.0% in 2022.

DNA and RNA sequencing practices are gaining traction owing to their ability to provide valuable data about gene sequences in a small duration of time. The data generated through gene sequencing is then analyzed and used by clinicians, scientists, and researchers across various verticals such as agriculture, forensics, etc.

Library preparation kits provide efficient and quick extraction of gene segments which are then used for analysis. Moreover, advancements in technology are encouraging manufacturers to launch novel products that reduce error and stress while improving accuracy.

Which is the leading application of metagenomics?

Clinical diagnostics to remain a key application area for metagenomics

By application, demand in the clinical diagnostics and bioremediation segments is expected to remain high over the forecast period. During the last few decades, metagenomics has gained immense traction across the healthcare industry where it is being utilized for diagnostic procedures.

Similarly, metagenomics procedures are being adopted for reducing toxicity in the environment. The rising usage of metagenomics in clinical diagnostics and bioremediation is anticipated to boost the growth in the market during the forecast period.

Which is the dominant end-use industry in the market?

Demand for metagenomics remains high in pharmaceutical industries and academic and research Institutes

In terms of end use, pharmaceutical, and academic & research segments are likely to generate the maximum revenue through 2033.

With the rising prevalence of multiple chronic diseases, pharmaceutical companies and government health organizations are investing in the development of innovative drugs. Thus, the application of metagenomics is expected to increase over the forecast period. Similarly, various research activities are being conducted across educational institutions for studying and elucidating the genetic structure of microbial communities.

Start-ups develop Automation enabled Metagenomics Solution

The start-ups have developed metagenomic screening tools to aid bio-discovery. The platform developed by them enables the expression of genes from diverse sources. The combination of automation, computation, and high-throughput screening assists in capturing a large variety of proteins.

Metagenomi: The start-up utilizes metagenomics to discover next-generation gene-editing tools. The discovery engine developed by Metagenomi uses AI-backed cloud computing to find natural enzyme systems in microbial environments. It finds compact nucleases that enable the delivery of AAV vectors. The search solution developed by them is mainly for therapeutic solutions. In January 2023, Metagenomi closed oversubscribed Series B funding standing at US$ 275 million to lead therapeutic programs into clinical development.

Key Manufacturers sign Strategic Collaborations to Enhance Research Prowess

The key players look to form profitable strategic collaborations. This would enable them to develop a combined framework of technologies that can increase the yield and find promising drugs based on human omics insights. In October 2022, Illumina launched a strategic collaboration with AstraZeneca for accelerating drug target discovery.

Key developments in the market are:

In November 2022, Illumina boosted its genomic innovation in the United Arab Emirates through a new state-of-the-art solutions center.
In November 2022, PerkinElmer helped accelerate gene therapy research with industry-first ready-to-use viral vector assays.

Dominant players in the market are:

Company	Description
Illumina	Illumina has always worked towards improving human health by unlocking the power of the genome. By delivering breakthroughs in genomics, the company empowers visionaries around the globe to uncover answers. The company has enabled researchers and clinicians to turn big dreams into impactful genomic discoveries that improve lives. Inspired by deep customer insights, Illumina leads the way in delivering purposeful advances that address critical needs and enable support researchers.
PerkinElmer	PerkinElmer is a global provider of end-to-end solutions which help scientists, researchers, and clinicians better diagnose disease. With more than an 8-decade legacy of advancing science, the team of more than 16,000 collaborates with healthcare, academic, commercial, and government customers. The company reported revenues of more than US$ 5 billion in 2021 and is currently serving in more than 190 countries. It is a component of the prestigious S&P 500 index.
Trivitron Healthcare Pvt. Ltd.	Being a part of this niche for more than two and a half decades, the journey of Trivitron as a medical technology presents a fascinating thread of inspiration. The company has been marketing its products to hospitals, healthcare providers, independent clinics, and laboratories. As a pioneer in this field, the company constantly pursues technological innovation to offer superior benefits at a lower cost. The company believes in delivering quality healthcare as a fundamental right.

Other prominent companies profiled: are Qiagen N.V., and Thermo Fisher Scientific.

Metagenomics Market Segmentation

By Product Type:

Library Preparation Kits
Sample Extraction Kits
Metagenomic Sequencing Kits

By Application:

Microbial Diversity
Bioremediation and Degradation
Bio Surfactants and Antibiotics Production
Clinical Diagnostics
Others

By End User:

Pharmaceutical Industries
Research Laboratories
Biotechnology Companies
Pathology Laboratories
Academic and Research Institutes

By Region:

North America
Latin America
Europe
Commonwealth of Independent States and Russia
Japan
Asia Pacific Excluding Japan
The Middle East and Africa

Frequently Asked Questions

What is the expected Metagenomics Market size in 2023?

The metagenomics market is expected to hold US$ 202.9 million in 2023.

At what rate would Metagenomics Market Grow?

The metagenomics market is expected to advance at 6.9% CAGR from 2023 to 2033.

What is the Demand Forecast for the Metagenomics Market?

The metagenomics market is forecasted to surpass US$ 394.2 million by 2033.

Which Region is expected to be Highly Significant Metagenomics Market?

North America is projected to be the dominant market for metagenomics.

What are the Main Drivers of the Metagenomics Market?

The main drivers are: surging cases of chronic illnesses and increasing investments by the government authorities.

Table of Content

1. Executive Summary | Metagenomics Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022

4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2022

5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033

5.3.1. Library Preparation Kits

5.3.2. Sample Extraction Kits

5.3.3. Sequencing Kits

5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022

5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2022

6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033

6.3.1. Microbial Diversity

6.3.2. Bioremediation and Degradation

6.3.3. Bio Surfactants and Antibiotics Production

6.3.4. Clinical Diagnostics

6.3.5. Others

6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022

6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2022

7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2023 to 2033

7.3.1. Pharmaceutical Industries

7.3.2. Research Laboratories

7.3.3. Biotechnology Companies

7.3.4. Pathology Laboratories

7.3.5. Academic and Research Institutes

7.3.6. Others

7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022

8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. CIS & Russia

8.3.5. Asia-Pacific excluding Japan (APEJ)

8.3.6. Japan

8.3.7. Middle East and Africa (MEA)

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

9.2.1. By Country

9.2.1.1. United States of America

9.2.1.2. Canada

9.2.2. By Product Type

9.2.3. By Application

9.2.4. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product Type

9.3.3. By Application

9.3.4. By End User

9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Product Type

10.2.3. By Application

10.2.4. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product Type

10.3.3. By Application

10.3.4. By End User

10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

11.2.1. By Country

11.2.1.1. EU-4

11.2.1.2. United Kingdom

11.2.1.3. BENELUX

11.2.1.4. Rest of Europe

11.2.2. By Product Type

11.2.3. By Application

11.2.4. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product Type

11.3.3. By Application

11.3.4. By End User

11.4. Key Takeaways

12. CIS & Russia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

12.2.1. By Country

12.2.2. By Product Type

12.2.3. By Application

12.2.4. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product Type

12.3.3. By Application

12.3.4. By End User

12.4. Key Takeaways

13. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

13.2.1. By Country

13.2.1.1. China

13.2.1.2. India

13.2.1.3. ASEAN

13.2.1.4. South Korea

13.2.1.5. Rest of APEJ

13.2.2. By Product Type

13.2.3. By Application

13.2.4. By End User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product Type

13.3.3. By Application

13.3.4. By End User

13.4. Key Takeaways

14. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

14.2.1. By Country

14.2.2. By Product Type

14.2.3. By Application

14.2.4. By End User

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product Type

14.3.3. By Application

14.3.4. By End User

14.4. Key Takeaways

15. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

15.2.1. By Country

15.2.1.1. GCC Countries

15.2.1.2. South Africa

15.2.1.3. Rest of MEA

15.2.2. By Product Type

15.2.3. By Application

15.2.4. By End User

15.3. Market Attractiveness Analysis

15.3.1. By Country

15.3.2. By Product Type

15.3.3. By Application

15.3.4. By End User

15.4. Key Takeaways

16. Key Countries Market Analysis

16.1. United States of America

16.1.1. Pricing Analysis

16.1.2. Market Share Analysis, 2022

16.1.2.1. By Product Type

16.1.2.2. By Application

16.1.2.3. By End User

16.2. Canada

16.2.1. Pricing Analysis

16.2.2. Market Share Analysis, 2022

16.2.2.1. By Product Type

16.2.2.2. By Application

16.2.2.3. By End User

16.3. Brazil

16.3.1. Pricing Analysis

16.3.2. Market Share Analysis, 2022

16.3.2.1. By Product Type

16.3.2.2. By Application

16.3.2.3. By End User

16.4. Mexico

16.4.1. Pricing Analysis

16.4.2. Market Share Analysis, 2022

16.4.2.1. By Product Type

16.4.2.2. By Application

16.4.2.3. By End User

16.5. EU-4

16.5.1. Pricing Analysis

16.5.2. Market Share Analysis, 2022

16.5.2.1. By Product Type

16.5.2.2. By Application

16.5.2.3. By End User

16.6. United Kingdom

16.6.1. Pricing Analysis

16.6.2. Market Share Analysis, 2022

16.6.2.1. By Product Type

16.6.2.2. By Application

16.6.2.3. By End User

16.7. BENELUX

16.7.1. Pricing Analysis

16.7.2. Market Share Analysis, 2022

16.7.2.1. By Product Type

16.7.2.2. By Application

16.7.2.3. By End User

16.8. CIS & Russia

16.8.1. Pricing Analysis

16.8.2. Market Share Analysis, 2022

16.8.2.1. By Product Type

16.8.2.2. By Application

16.8.2.3. By End User

16.9. China

16.9.1. Pricing Analysis

16.9.2. Market Share Analysis, 2022

16.9.2.1. By Product Type

16.9.2.2. By Application

16.9.2.3. By End User

16.10. India

16.10.1. Pricing Analysis

16.10.2. Market Share Analysis, 2022

16.10.2.1. By Product Type

16.10.2.2. By Application

16.10.2.3. By End User

16.11. ASIAN

16.11.1. Pricing Analysis

16.11.2. Market Share Analysis, 2022

16.11.2.1. By Product Type

16.11.2.2. By Application

16.11.2.3. By End User

16.12. South Korea

16.12.1. Pricing Analysis

16.12.2. Market Share Analysis, 2022

16.12.2.1. By Product Type

16.12.2.2. By Application

16.12.2.3. By End User

16.13. Japan

16.13.1. Pricing Analysis

16.13.2. Market Share Analysis, 2022

16.13.2.1. By Product Type

16.13.2.2. By Application

16.13.2.3. By End User

16.14. GCC Countries

16.14.1. Pricing Analysis

16.14.2. Market Share Analysis, 2022

16.14.2.1. By Product Type

16.14.2.2. By Application

16.14.2.3. By End User

16.15. South Africa

16.15.1. Pricing Analysis

16.15.2. Market Share Analysis, 2022

16.15.2.1. By Product Type

16.15.2.2. By Application

16.15.2.3. By End User

17. Market Structure Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Market Share Analysis of Top Players

17.3.1. By Regional

17.3.2. By Product Type

17.3.3. By Application

17.3.4. By End User

18. Competition Analysis

18.1. Competition Deep Dive

18.1.1. Illumina Inc

18.1.1.1. Overview

18.1.1.2. Product Portfolio

18.1.1.3. Profitability by Market Segments

18.1.1.4. Sales Footprint

18.1.1.5. Strategy Overview

18.1.1.5.1. Marketing Strategy

18.1.2. Perkin Elmer Inc.

18.1.2.1. Overview

18.1.2.2. Product Portfolio

18.1.2.3. Profitability by Market Segments

18.1.2.4. Sales Footprint

18.1.2.5. Strategy Overview

18.1.2.5.1. Marketing Strategy

18.1.3. Trivitron Healthcare Pvt. Ltd.

18.1.3.1. Overview

18.1.3.2. Product Portfolio

18.1.3.3. Profitability by Market Segments

18.1.3.4. Sales Footprint

18.1.3.5. Strategy Overview

18.1.3.5.1. Marketing Strategy

18.1.4. Qiagen N.V.

18.1.4.1. Overview

18.1.4.2. Product Portfolio

18.1.4.3. Profitability by Market Segments

18.1.4.4. Sales Footprint

18.1.4.5. Strategy Overview

18.1.4.5.1. Marketing Strategy

18.1.5. Thermo Fisher Scientific

18.1.5.1. Overview

18.1.5.2. Product Portfolio

18.1.5.3. Profitability by Market Segments

18.1.5.4. Sales Footprint

18.1.5.5. Strategy Overview

18.1.5.5.1. Marketing Strategy

18.1.6. Symbio Scientific Pvt. Ltd.

18.1.6.1. Overview

18.1.6.2. Product Portfolio

18.1.6.3. Profitability by Market Segments

18.1.6.4. Sales Footprint

18.1.6.5. Strategy Overview

18.1.6.5.1. Marketing Strategy

18.1.7. Infobio

18.1.7.1. Overview

18.1.7.2. Product Portfolio

18.1.7.3. Profitability by Market Segments

18.1.7.4. Sales Footprint

18.1.7.5. Strategy Overview

18.1.7.5.1. Marketing Strategy

18.1.8. Bio-Rad Laboratories

18.1.8.1. Overview

18.1.8.2. Product Portfolio

18.1.8.3. Profitability by Market Segments

18.1.8.4. Sales Footprint

18.1.8.5. Strategy Overview

18.1.8.5.1. Marketing Strategy

18.1.9. Merck KgaA

18.1.9.1. Overview

18.1.9.2. Product Portfolio

18.1.9.3. Profitability by Market Segments

18.1.9.4. Sales Footprint

18.1.9.5. Strategy Overview

18.1.9.5.1. Marketing Strategy

18.1.10. Promega Corporation

18.1.10.1. Overview

18.1.10.2. Product Portfolio

18.1.10.3. Profitability by Market Segments

18.1.10.4. Sales Footprint

18.1.10.5. Strategy Overview

18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

List of Tables

Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 3: Global Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 4: Global Market Value (US$ million) Forecast by End User, 2017 to 2033

Table 5: North America Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 6: North America Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 7: North America Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 8: North America Market Value (US$ million) Forecast by End User, 2017 to 2033

Table 9: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 10: Latin America Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 11: Latin America Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 12: Latin America Market Value (US$ million) Forecast by End User, 2017 to 2033

Table 13: Europe Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 14: Europe Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 15: Europe Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 16: Europe Market Value (US$ million) Forecast by End User, 2017 to 2033

Table 17: CIS & Russia Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 18: CIS & Russia Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 19: CIS & Russia Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 20: CIS & Russia Market Value (US$ million) Forecast by End User, 2017 to 2033

Table 21: APEJ Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 22: APEJ Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 23: APEJ Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 24: APEJ Market Value (US$ million) Forecast by End User, 2017 to 2033

Table 25: Japan Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 26: Japan Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 27: Japan Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 28: Japan Market Value (US$ million) Forecast by End User, 2017 to 2033

Table 29: MEA Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 30: MEA Market Value (US$ million) Forecast by Product Type, 2017 to 2033

Table 31: MEA Market Value (US$ million) Forecast by Application, 2017 to 2033

Table 32: MEA Market Value (US$ million) Forecast by End User, 2017 to 2033

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ million) by Product Type, 2023 to 2033

Figure 2: Global Market Value (US$ million) by Application, 2023 to 2033

Figure 3: Global Market Value (US$ million) by End User, 2023 to 2033

Figure 4: Global Market Value (US$ million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ million) Analysis by Region, 2017 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 11: Global Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 14: Global Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Application, 2023 to 2033

Figure 19: Global Market Attractiveness by End User, 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ million) by Product Type, 2023 to 2033

Figure 22: North America Market Value (US$ million) by Application, 2023 to 2033

Figure 23: North America Market Value (US$ million) by End User, 2023 to 2033

Figure 24: North America Market Value (US$ million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 31: North America Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 34: North America Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Application, 2023 to 2033

Figure 39: North America Market Attractiveness by End User, 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ million) by Product Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ million) by Application, 2023 to 2033

Figure 43: Latin America Market Value (US$ million) by End User, 2023 to 2033

Figure 44: Latin America Market Value (US$ million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 54: Latin America Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ million) by Product Type, 2023 to 2033

Figure 62: Europe Market Value (US$ million) by Application, 2023 to 2033

Figure 63: Europe Market Value (US$ million) by End User, 2023 to 2033

Figure 64: Europe Market Value (US$ million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 71: Europe Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 74: Europe Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 77: Europe Market Attractiveness by Product Type, 2023 to 2033

Figure 78: Europe Market Attractiveness by Application, 2023 to 2033

Figure 79: Europe Market Attractiveness by End User, 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: CIS & Russia Market Value (US$ million) by Product Type, 2023 to 2033

Figure 82: CIS & Russia Market Value (US$ million) by Application, 2023 to 2033

Figure 83: CIS & Russia Market Value (US$ million) by End User, 2023 to 2033

Figure 84: CIS & Russia Market Value (US$ million) by Country, 2023 to 2033

Figure 85: CIS & Russia Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 86: CIS & Russia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: CIS & Russia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: CIS & Russia Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 89: CIS & Russia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 90: CIS & Russia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 91: CIS & Russia Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 92: CIS & Russia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 93: CIS & Russia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 94: CIS & Russia Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 95: CIS & Russia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 96: CIS & Russia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 97: CIS & Russia Market Attractiveness by Product Type, 2023 to 2033

Figure 98: CIS & Russia Market Attractiveness by Application, 2023 to 2033

Figure 99: CIS & Russia Market Attractiveness by End User, 2023 to 2033

Figure 100: CIS & Russia Market Attractiveness by Country, 2023 to 2033

Figure 101: APEJ Market Value (US$ million) by Product Type, 2023 to 2033

Figure 102: APEJ Market Value (US$ million) by Application, 2023 to 2033

Figure 103: APEJ Market Value (US$ million) by End User, 2023 to 2033

Figure 104: APEJ Market Value (US$ million) by Country, 2023 to 2033

Figure 105: APEJ Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 106: APEJ Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: APEJ Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: APEJ Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 109: APEJ Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 110: APEJ Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 111: APEJ Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 112: APEJ Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 113: APEJ Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 114: APEJ Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 115: APEJ Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 116: APEJ Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 117: APEJ Market Attractiveness by Product Type, 2023 to 2033

Figure 118: APEJ Market Attractiveness by Application, 2023 to 2033

Figure 119: APEJ Market Attractiveness by End User, 2023 to 2033

Figure 120: APEJ Market Attractiveness by Country, 2023 to 2033

Figure 121: Japan Market Value (US$ million) by Product Type, 2023 to 2033

Figure 122: Japan Market Value (US$ million) by Application, 2023 to 2033

Figure 123: Japan Market Value (US$ million) by End User, 2023 to 2033

Figure 124: Japan Market Value (US$ million) by Country, 2023 to 2033

Figure 125: Japan Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 126: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 127: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 128: Japan Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 129: Japan Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 130: Japan Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 131: Japan Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 132: Japan Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 133: Japan Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 134: Japan Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 135: Japan Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 136: Japan Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 137: Japan Market Attractiveness by Product Type, 2023 to 2033

Figure 138: Japan Market Attractiveness by Application, 2023 to 2033

Figure 139: Japan Market Attractiveness by End User, 2023 to 2033

Figure 140: Japan Market Attractiveness by Country, 2023 to 2033

Figure 141: MEA Market Value (US$ million) by Product Type, 2023 to 2033

Figure 142: MEA Market Value (US$ million) by Application, 2023 to 2033

Figure 143: MEA Market Value (US$ million) by End User, 2023 to 2033

Figure 144: MEA Market Value (US$ million) by Country, 2023 to 2033

Figure 145: MEA Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 148: MEA Market Value (US$ million) Analysis by Product Type, 2017 to 2033

Figure 149: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033

Figure 151: MEA Market Value (US$ million) Analysis by Application, 2017 to 2033

Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033

Figure 154: MEA Market Value (US$ million) Analysis by End User, 2017 to 2033

Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 157: MEA Market Attractiveness by Product Type, 2023 to 2033

Figure 158: MEA Market Attractiveness by Application, 2023 to 2033

Figure 159: MEA Market Attractiveness by End User, 2023 to 2033

Figure 160: MEA Market Attractiveness by Country, 2023 to 2033